Cleared Traditional

K941425 - ALAMAR ANTIBIOTIC SUSCEPTIBILITY

K941425 is an FDA 510(k) clearance for ALAMAR ANTIBIOTIC SUSCEPTIBILITY, manufactured by Alamar Biosciences Laboratory, Inc.. The device is a Class 2 Microbiology device with product code LRG cleared through the Traditional 510(k) pathway after a 267-day FDA review.

K941425 · Alamar Biosciences Laboratory, Inc. · Microbiology device
Download Printable Device Report (PDF)
Optimized for regulatory review, auditing and printing
Dec 1994
Decision
267d
Days
Class 2
Risk

K941425 is an FDA 510(k) clearance for the ALAMAR ANTIBIOTIC SUSCEPTIBILITY. Classified as Instrument For Auto Reader & Interpretation Of Overnight Suscept. Systems (product code LRG), Class II - Special Controls.

Submitted by Alamar Biosciences Laboratory, Inc. (Sacramento, US). The FDA issued a Cleared decision on December 15, 1994 after a review of 267 days - an extended review cycle.

This device falls under the Microbiology FDA review panel, regulated under 21 CFR 866.1640 - the FDA microbiology device framework. The Traditional 510(k) pathway establishes clearance through substantial equivalence to a legally marketed predicate device, without requiring clinical trial data.

Device pattern: Standard predicate-based submission. Standard predicate reliance. This clearance follows a standard predicate-based equivalence path within the Microbiology review framework, consistent with the majority of Class II 510(k) submissions.

View all Alamar Biosciences Laboratory, Inc. devices

FDA 510(k) Submission Details - K941425

510(k) Number K941425 FDA.gov
FDA Decision Cleared Substantially Equivalent - Traditional 510(k) (SESE)
Date Received March 23, 1994
Decision Date December 15, 1994
Days to Decision 267 days
Submission Type Traditional
Review Panel Microbiology (MI)
Summary Statement
Third-party Review No - reviewed directly by FDA
Combination Product No
PCCP Authorized No
Regulatory Context
Review time vs. panel average
165d slower than avg
Panel avg: 102d · This submission: 267d
Pathway characteristics
Predicate-based equivalence. No clinical trials required.

LRG Device Classification - Class 2, Special Controls

Product Code LRG Instrument For Auto Reader & Interpretation Of Overnight Suscept. Systems
Device Class Class 2 - Special Controls
CFR Regulation 21 CFR 866.1640
What this classification means

Class II devices require demonstration of substantial equivalence to a legally marketed predicate device. This pathway does not require clinical trials - it relies on engineering equivalence and performance data. Most Microbiology devices follow this clearance model.

Regulatory Peers - LRG Instrument For Auto Reader & Interpretation Of Overnight Suscept. Systems

All 39
Devices cleared under the same product code (LRG) and FDA review panel - the closest regulatory comparables to K941425.
MICROSCAN SYNERGIES PLUS GRAM-NEGATIVE MIC/COMBO PANELS
K041150 · Dade Behring, Inc. · Jul 2004
MICROSCAN DRIED GRAM-NEGATIVE MIC/COMBO PANELS (GEMIFLOXACIN)
K033948 · Dade Behring, Inc. · Mar 2004
MICROSCAN DRIED GRAM NEGATIVE MIC/COMBO PANELS , ESBL SCREEN
K981199 · Dade Microscan, Inc. · Nov 1998
SYNERGY SCREEN TEST, MODIFICATION
K921977 · Baxter Healthcare Corp · Oct 1993
READAR
K925951 · Alamar Biosciences Laboratory, Inc. · Aug 1993
MICROSCAN DRI GRAM POSIT/GRAM NEGA MIC/COMBO PANEL
K922482 · Baxter Diagnostics, Inc. · Mar 1993